Background: For diagnosis of post-traumatic stress disorder (PTSD), the Clinician-Administered PTSD Scale (CAPS) is one of the most widely used structured diagnostic interviews. Methods: In this study, we aimed to develop and validate the Korean version of CAPS for the Diagnostic and Statistical Manual of Mental Disorders, 5th edition ([DSM-5] K-CAPS-5). Seventy-one subjects with PTSD, 74 with mood disorder or anxiety disorder, and 99 as healthy controls were enrolled. The Korean version of the structured clinical interview for DSM-5-research version was used to assess the convergent validity of K-CAPS-5. BDI-II, BAI, IES-R, and STAI was used to evaluate the concurrent validity. Results: All subjects completed various psychometric assessments including K-CAPS-5. K-CAPS-5 presented good internal consistency (Cronbach's α = 0.92) and test-retest reliability (r = 0.91). K-CAPS-5 showed strong correlations with the structured clinical interview for DSM-5 PTSD (k = 0.893). Among the three subject groups listed above there were significant differences in the K-CAPS-5 total score. The data were best explained by a six-factor model. Conclusion: These results demonstrated the good reliability and validity of K-CAPS-5 and its suitability for use as a simple but structured instrument for PTSD assessment.
INTRODUCTION
The Clinician-Administered Posttraumatic Stress Disorder Scale (CAPS) is the gold standard and one of the most widely used structured diagnostic interviews of post-traumatic stress disorder (PTSD). 1,2 CAPS for the Diagnostic and Statistical Manual of Mental Disorders, 5th edition ([DSM-5] CAPS-5) 3 is a 30-item questionnaire and the full interview takes 45-60 minutes. The instrument allows quantification of the frequency and intensity of the 20 PTSD symptoms according to DSM-5. 4 In addition to evaluating the 20 DSM-5 PTSD symptoms, the other 10 questions address the index trauma event, duration of symptoms, subjective distress, influence of symptoms on social and occupational functioning, overall response validity, overall PTSD severity, improvement in PTSD symptoms since a previous CAPS administration, and specifications for the dissociative subtype.
Several important revisions were made to the CAPS in updating it for DSM-5. First, CAPS for DSM-5 asked respondents to keep in mind three traumatic events during the interview. But, CAPS-5 uses the identification of a single index trauma to serve as the basis of symptom inquiry. Second, CAPS-5 is corresponding to the DSM-5 diagnosis for PTSD. The expression of the CAPS-5 included both changes to existing symptoms and the addition of new symptoms in DSM-5. CAPS-5 assesses the dissociative subtype of PTSD (depersonalization and derealization), but no longer evaluates other associated symptoms (e.g., gaps in awareness). Third, as with the CAPS for DSM-5, CAPS-5 symptom severity ratings relied on symptom frequency and intensity. However, CAPS-5 items are rated with a single severity score in contrast to the CAPS for DSM-5 which required separate frequency and intensity scores. Fourth, the CAPS-5 includes general instructions and scoring information. 3 Structured interviews used to diagnose PTSD include the PTSD Interview, the Structured Interview for PTSD, and CAPS. The PTSD Interview is a questionnaire format, so it can be influenced by the response of the subject and there is a limitation in that an inaccurate selfevaluation may lead to a deviation. 5 The Structured Interview for PTSD has the disadvantage of diagnosing PTSD based on the worst memory of the whole life. 6 CAPS has a disadvantage that it takes a lot of time for testing and it is not valid for non-experts to inspect. However, because symptoms of PTSD are clearly distinguished by frequency and intensity, they are widely used in research and clinical fields in the world. 3 In CAPS-5, the Life Events Checklist for DSM-5 (LEC-5) 7 is recommended to identify an index traumatic event. LEC-5 covered various stressful events such as natural disaster, fire or explosion, transportation accident, serious accident, exposure to toxic substance, physical assault, sexual assault, combat, life-threatening illness and so on. In addition, LEC-5 can distinguish the experience of index trauma by whether subjects undergo index trauma, whether subjects witnessed index trauma, whether index trauma happened to a person close to the subjects, and whether subjects experienced occupational index trauma. CAPS-5 symptoms cluster severity scores are calculated by summing each item severity score for symptoms corresponding to the intrusion, avoidance, cognition/mood, and arousal/reactivity clusters. The intrusion, avoidance, cognition/mood, and arousal/reactivity clusters consist of 5, 2, 7 and 6 items, respectively. CAPS-5 is divided into three versions according to the period; past week, past month, and worst month. Because CAPS-5 faithfully reflects DSM-5, PTSD can be diagnosed if it involves one or more intrusion symptoms, one or more avoidance symptoms, two or more cognition/mood symptoms, two or more arousal/reactivity symptoms, a period of one month or more, and significant distress or functional impairment. 4 Although the CAPS for DSM-5 had excellent psychometric properties 8, 9 and has been standardized in Korean, 10 many changes were made to the PTSD diagnosis in DSM-5. While PTSD used to be categorized with the anxiety disorders in DSM-5, it now has been moved into a separate chapter called "Trauma-and Stress-Related Disorders" in DSM-5. Further, although the duration of the diagnosis has not been changed, the PTSD symptoms, which were classified into three categories of reexperience, avoidant/numbing and hyper-arousal in DSM-5, have been re-classified into 4 clusters of intrusion, avoidance, cognition/mood, and arousal/reactivity in DSM-5. 4 These changes necessitate standardization of CAPS-5 for a Korean version.
In this study, we aimed to develop and validate the Korean version of CAPS-5 (K-CAPS-5). After translating CAPS-5 into Korean language while maintaining its basic structure, we assessed the validity and the reliability of K-CAPS-5 for testing the usefulness in Korean PTSD patients.
METHODS

Subjects
A total of 274 subjects were recruited from 8 medical institutions throughout Korea, from February 2016 until March 2017. The 274 study subjects comprised 71 with PTSD, 74 with mood disorder or anxiety disorder as a psychiatric control group, and 99 as a healthy control group. PTSD and other psychiatric disorders were diagnosed by the structured clinical interview for DSM-5-research version (SCID-5-RV). 11 The SCID-5-RV is a semi-structured interview guide for making DSM-5 diagnoses, including depression, anxiety, and PTSD. Interviewer training consisted of lectures on the SCID-5-RV and related questionnaires, observation of an evaluation performed by an experienced psychiatrist, and group evaluation of videos of PTSD patients. The diagnoses of subjects in the psychiatric control included major depressive disorder (n = 44), panic disorder (n = 6), and generalized anxiety disorder (n = 24). The healthy control group included 88 randomly selected individuals visiting the institutions for regular health screening. All the healthy controls demonstrated that they did not have a lifetime history of psychiatric disorders in SCID-5-RV.
Exclusion criteria for psychiatric disorders were being younger than 18 or older than 70 years, having been diagnosed with a present or past diagnosis of psychotic disorders, and were not able to complete the CAPS-5 interview. To assess test-retest reliability, only the PTSD patients with stable PTSD symptoms and who agreed to a second K-CAPS-5 assessment were included.
Measurement instruments
After obtaining permission from the National Center for PTSD, three bilingual psychiatrists and one psychologist in English and Korean initially translated CAPS-5; this was followed by a process of back translation and revisions. Two other bilingual Korean psychiatrists and one psychologist performed the back translation blindly. Finally, a translation committee, which consisted of five Korean psychiatrists, one Korean language and literature professor, and one psychologist, made the final version of K-CAPS-5.
The Korean version of SCID-5-RV (K-SCID-RV) was used to assess the convergent validity of K-CAPS-5. We used SCID-RV as the gold standard assessment of DSM-5 PTSD. SCID-5-RV is a semi-structured interview guide for making DSM-5 diagnoses for depression, anxiety and PTSD. It was administered by trained mental health professionals that were familiar with the DSM-5 classification and diagnostic criteria.
The Beck Depression Inventory-II (BDI-II), 12 the Beck Anxiety Inventory (BAI), 13 the Impact of Event Scale-Revised (IES-R), 14 and the Spielberger State Trait Anxiety Inventory (STAI) 15 were also performed to assess the correlations with the scores of K-CAPS-5. BDI-II, a 21-item self-administered questionnaire, was designed to evaluate the severity of depression, and BAI with 21 items for evaluating the severity of anxiety. IES-R, a 22-item self-reporting questionnaire composed 8 questions for intrusion, 8 for avoidance, and 6 for hyperarousal, was used to assess the severity of PTSD symptoms. STAI, with 40 self-check questions, was developed to assess the severity of state anxiety and trait anxiety. The Korean versions of BDI, BAI, IES-R and STAI have previously been shown to exhibit excellent psychometric properties, and their internal consistency coefficients were reported to be 0.85, 16 0.90, 17 0.76, 18 and 0.91, 19 respectively. The 8 interviewers in this study were skilled board-certificated psychiatrists and clinical psychologists with careers in PTSD practice of at least five years. The consensus meeting consisted of lecturing on K-CAPS-5 and related questionnaire characteristics, observing the evaluation by an experienced psychiatrist, and evaluating the video-recorded PTSD patients together. The inter-rater reliability values of the PTSD module of SCID-RV and K-CAPS-5 were high, with intra-class correlation coefficients of 0.74 and 0.80, respectively.
Statistical analyses
Among the PTSD, psychiatric control, and normal control groups, demographic variables and clinical characteristics were compared using the analysis of variance (ANOVA) and χ 2 analyses to compare the quantitative and categorical variables. In order to measure the internal consistencies of K-CAPS-5, Cronbach's alpha coefficients were computed, and the item-total correlation coefficients of these scales were measured to confirm that all the items on these scales also exhibited internal consistency. Test-retest reliability and the inter-rater reliability were calculated by means of the intraclass correlation coefficients. Test-retest reliability was evaluated by the same interviewers who performed the two testing sessions within 5 days. To measure the agreement of each item between K-CAPS-5 and SCID-5-RV, Pearson's χ 2 and Cohen's κ coefficient were calculated. Cohen's κ coefficient ranges from 0 to 1; values of 0.8 and over are considered to indicate 'good agreement' and values of 0.6-0.8 are considered to indicate substantial agreement. 20 Pearson correlation coefficients were used to evaluate the concurrent validity between K-CAPS-5, BDI-II, BAI, IES-R, and STAI. ANOVA with Tukey's post hoc test was performed to evaluate the between-group difference by the severity measured by K-CAPS-5. An exploratory factor analysis was performed using principal component analysis with varimax rotation to determine the factor structure of K-CAPS-5. The optimal cutoff scores of K-CAPS-5 that best predicted current PTSD by SCID-5-RV were estimated by receiver operating characteristics curve analysis. The sensitivities, specificities, positive predictive values, negative predictive values, and κ values were measured for each threshold score of K-CAPS-5.
Analyses were performed using SPSS version 18.0 (SPSS, Chicago, IL, USA). Statistical significance was set at P < 0.05.
Ethics statement
This study was approved by the public Institutional Review Board of the Ministry of Health and Welfare of Korea (P01-201508-21-002). All subjects were informed of the study purpose and methods and provided written informed consent.
RESULTS
Demographics and clinical characteristics
The mean ages of the PTSD, psychiatric control, and normal control groups were 46.9 (standard deviation [SD], 14.3), 43.7 (SD, 12.1), and 44.6 (SD, 9.2) years, respectively. The numbers of males in the three groups were 42 (60.0%), 34 (45.9%), and 37 (37.4%), respectively. No significant differences were found for age (F = 1.433, P = 0.241), although a significant difference in gender ratio was found among the three groups (χ 2 = 8.452, P = 0.015). There was no significant difference in marital status among the three groups. The mean duration of symptoms in the PTSD group was 22.31 (SD, 29.17; range, 1.10-126.67) months. The worst traumas experienced in the PTSD group were serious accidents, such as automobile or man-made disasters (n = 51, 72.9%), physical assault (n = 7, 10.0%), sexual abuse (n = 6, 28.6%), combat experience (n = 2, 2.9%), life-threating medical disease (n = 2, 2.9%), and witnessing an accident (n = 2, 2.9%).
Reliability
Cronbach's α was used to evaluate the internal consistency of K-CAPS-5 in the 71 PTSD patients. Internal consistency for the K-CAPS-5 total score was 0.92 at baseline. Alpha coefficients for intrusion, avoidance, cognition/mood, and arousal/reactivity were 0.83, 0.71, 0.82, and 0.75, respectively. Based on the criterion of 0.30 as an acceptable corrected itemtotal correlation, 19 all 20 items performed adequately (range, 0.38-0.79) ( Table 1) .
Among the 71 PTSD subjects, 34 were recruited for the evaluation of the test-retest reliability. The test-retest reliability was determined to be 0.91 (P < 0.001). 
Validity
The total scores ± standard error (SE) of K-CAPS-5 in the PTSD group, the psychiatric controls and normal controls were 33.03 ± 1.07, 18.00 ± 9.79, and 6.18 ± 5.86, respectively. These values were significantly different by ANOVA (overall F = 115.87, P < 0.001). The Tukey's post-hoc test showed that there were significant differences among the three groups. These results showed the good construct validity of K-CAPS-5. Table 2 shows the value of Pearson's χ 2 and Cohen's κ coefficient between K-CAPS-5 and SCID-5. Both PTSD diagnosis (κ = 0.893) and dissociative subtype of PTSD were in almost perfect agreement (κ = 0.839). According to the detailed diagnosis criteria, Cohen's κ coefficient of traumatic experience was 0.705, which corresponds to substantial agreement, and Cohen's κ coefficients of intrusion, avoidance, cognition/mood, and arousal/reactivity were all more than 0.910, which were in almost perfect agreement.
The total K-CAPS-5 score was correlated with BDI (r = 0.58, P < 0.001), BAI (r = 0.67, P < 0.001), IES-R (r = 0.78, P < 0.001), and STAI-T (r = 0.37, P = 0.003). Thus, the correlation of K-CAPS-5 was strong with IES-R, relatively weak with STAI-T, and intermediated with BDI-II ( Reliability and Validity of K-CAPS-5 The explorative factor analysis with varimax rotation on the items of K-CAPS-5 for the 71 subjects from the PTSD group yielded six factors that explained the results and which together accounted for 61.91% of the variance ( Table 4) 
DISCUSSION
CAPS-5 is a current tool that should be standardized for PTSD studies because it clearly measures the severity of PTSD symptoms, despite its disadvantages of taking a lot of time and not being valid for non-specialists. Unlike previous versions, no study has validated CAPS-5. This study developed K-CAPS-5 using various tools, including SCID-5-RV, and presented good reliability and validity.
In this study, K-CAPS-5 presented good reliability. The excellent internal consistency of K-CAPS-5 was demonstrated by Cronbach's α of 0.92. 21 - 23 The coefficient of the four PTSD symptom clusters was within the optimal range, considering that an optimal value of α should be between 0.70 and 0.90. 24 The test-retest reliability of K-CAPS-5 was determined to be 0.91. The test-retest interval in this study was two weeks. In clinical situations, longer test-retest intervals might cause greater PTSD symptom changes. Most of the PTSD subjects included in this study were chronic types whose mean duration of symptoms was 4.2 years, and no subject presented any PTSD symptom changes. Thus, we could conclude that K-CAPS-5 has good reliability.
The PTSD diagnoses of K-CAPS-5 and SCID-5-RV were in substantial agreement (κ = 0.893). Most items of K-CAPS-5 and SCID-5-RV were in almost perfect agreement (κ > 0.81), except a few items such as subjective distress, and influence of symptoms on social functioning (κ = 0.61-0.80). In SCID-5-RV, the symptom-related distress or functional impairment was evaluated as one item. On the other hand, in K-CAPS-5, the item was evaluated as three items: Subjective distress, Influence of symptoms on social functioning and Influence of symptoms on occupational functioning. The agreement of functional impairment may be reduced because of the differences in these evaluation methods. Thus, K-CAPS-5 could be ideal for diagnosing PTSD.
In the comparison of the three groups of severity scores of K-CAPS-5, the PTSD group showed the highest average, followed by the psychiatric control and normal groups. K-CAPS-5 includes cognition/mood items, as well as other items such as intrusion, avoidance, and arousal/reactivity. In addition, the CAPS for DSM-4 was known as being partially correlated with depressive or anxiety disorders, so the total severity scores of the CAPS-5 score of the psychiatric control group were higher than those of the normal control group. 10 K-CAPS-5 was highly correlated with IES-R in the similar constructs, but less strongly correlated with other less relevant measuring constructs, such as depressive symptoms and anxiety symptoms. Also, K-CAPS-5 was not correlated with STAI-S. These correlations demonstrate the reasonable discriminant validity of this task as a measure for assessing PTSD symptoms. This result was similar to the results of one previous study conducted in Korea on the CAPS for DSM-IV standardization. 10 In the factor analysis of K-CAPS-5, six factors were generated though the explained variance (61.91%). The six-factor model differed from the diagnostic criteria of DSM-5 PTSD. Other researchers have suggested six-or seven-factor model that are the anhedonia model, 24 externalizing behavior model, 25 and hybrid model. 26 There was no change in the four factors of DSM-5 PTSD, because the six-or seven-factor model of PTSD divided "negative alterations in cognitions and mood" and "alterations in arousal and reactivity" criteria in detail. However, in this study, sleep disturbance and hyperarousal were analyzed as two new factors. Because sleep disturbances such as insomnia and nightmares are core components of PTSD, 27 sleep disturbance might be separated as a new factor. Several studies suggested that the separation of hyperarousal from "arousal/reactivity" might be appropriate. 28 - 34 Because the results of this study may be due to the small number of PTSD subjects, factor analysis with more subjects is needed.
Several limitations of the present study should be considered. First, the number of the index traumatic events of the PTSD group were relatively small; thus no difference among the PTSD symptoms could be distinguished according to each index traumatic event. Second, the proportion of males in the PTSD group was higher than that in the other groups. Women are more vulnerable to PTSD and are more likely to develop PTSD than men, 35 so a future study with a slightly higher proportion of women with PTSD will be more representative. Finally, the normal group did not experience any traumatic event that satisfies the DSM-5 diagnostic criteria A of PTSD. In one previous study, patients who experienced the same traumatic event were compared with the PTSD and control groups to evaluate the reliability and validity of CAPS. 35 In conclusion, K-CAPS-5 had good psychometric properties and may be used as a reliable and valid instrument to diagnose and assess PTSD according to DSM-5. More studies are needed to compare patients with PTSD and control in the same index traumatic event with CAPS-5.
